Literature DB >> 6658949

Treatment after transient ischemic attacks: a comparison between anticoagulant drug and inhibition of platelet aggregation.

A Gårde, K Samuelsson, H Fahlgren, E Hedberg, L G Hjerne, J Ostman.   

Abstract

Treatment with an anticoagulant (AC) or acetylsalicylic acid (ASA), chosen at random, was given to 241 patients with symptoms of carotid transient attacks of ischemia, some of whom recovered completely within 24 hours (TIA) while the others had slight residual symptoms (TIA-IR). Cerebral infarction was recorded in 4 patients in each of these treatment groups during a mean follow-up period of 20 months. The incidences of TIA and TIA-IR were also similar in the two groups. Severe hemorrhage occurred more often in the AC group, whereas other side reactions, including gastrointestinal disorders, were more common in the ASA group. Recurrent cerebral ischemic events were significantly more common among the patients that had had greater than or equal to 2 TIAs in the 14 days immediately preceding randomization, and in those with a history of CVS symptoms more than 14 days before randomization, or those with a carotid bruits. In the group experiencing greater than or equal to 2 TIAs in the 14 days prior to randomization the incidence of recurrent cerebral ischemic events was the same for the two types of treatment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6658949     DOI: 10.1161/01.str.14.5.677

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

1.  Transluminal angioplasty for arteriosclerotic disease of the distal vertebral and basilar arteries.

Authors:  T Terada; R T Higashida; V V Halbach; C F Dowd; E Nakai; H Yokote; T Itakura; G B Hieshima
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-04       Impact factor: 10.154

2.  Recent developments in the diagnosis and management of stroke.

Authors:  S Solomon
Journal:  Bull N Y Acad Med       Date:  1986-04

Review 3.  Transient ischemic attacks and stroke.

Authors:  T R Mirsen; V C Hachinski
Journal:  CMAJ       Date:  1988-06-15       Impact factor: 8.262

Review 4.  Vitamin K antagonists versus antiplatelet therapy after transient ischaemic attack or minor ischaemic stroke of presumed arterial origin.

Authors:  Els Llm De Schryver; Ale Algra; L Jaap Kappelle; Jan van Gijn; Peter J Koudstaal
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

Review 5.  Cost-effective intervention in stroke.

Authors:  D Dunbabin
Journal:  Pharmacoeconomics       Date:  1992-12       Impact factor: 4.981

6.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

7.  Audit of cranial computerised tomography in a general medical unit.

Authors:  P Curley; T Lynch; F Walker; J S Doyle
Journal:  Ir J Med Sci       Date:  1990-07       Impact factor: 1.568

Review 8.  Safety of treatment with oral anticoagulants in the elderly. A systematic review.

Authors:  B A Hutten; A W Lensing; R A Kraaijenhagen; M H Prins
Journal:  Drugs Aging       Date:  1999-04       Impact factor: 3.923

9.  A multiparametric index of platelet in vitro aggregation in cerebrovascular disease.

Authors:  P P Gazzaniga; P Ferroni; C Mina; F M Pulcinelli; P A Rizzo
Journal:  Ital J Neurol Sci       Date:  1987-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.